{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T13:40:46Z","timestamp":1793194846287,"version":"4.5.0"},"reference-count":55,"publisher":"Elsevier BV","issue":"12","license":[{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"vor","delay-in-days":365,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["mp.uscap.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Modern Pathology"],"published-print":{"date-parts":[[2022,12]]},"DOI":"10.1038\/s41379-022-01138-z","type":"journal-article","created":{"date-parts":[[2022,7,23]],"date-time":"2022-07-23T06:02:46Z","timestamp":1658556166000},"page":"1837-1847","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":38,"title":["Identification of fusions with potential clinical significance in melanoma"],"prefix":"10.1016","volume":"35","author":[{"given":"Jakob M.T.","family":"Moran","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Long P.","family":"Le","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Valentina","family":"Nardi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Josephine","family":"Golas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0977-530X","authenticated-orcid":false,"given":"Alexander A.","family":"Farahani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sylvia","family":"Signorelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maristela L.","family":"Onozato","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruth K.","family":"Foreman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lyn M.","family":"Duncan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Donald P.","family":"Lawrence","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2434-4978","authenticated-orcid":false,"given":"Jochen K.","family":"Lennerz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1174-3972","authenticated-orcid":false,"given":"Dora","family":"Dias-Santagata","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1406-7981","authenticated-orcid":false,"given":"Mai P.","family":"Hoang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1038\/s41379-022-01138-z_bib1","doi-asserted-by":"crossref","unstructured":"Matthews, N.H., Li, W.Q., Qureshi, A.A., Weinstock, M.A., Cho, E. Epidemiology of Melanoma. In: Ward WH, Farma JM, editors. Cutaneous Melanoma: Etiology and Therapy [Internet]. Brisbane (AU): Codon Publications (2017). Chapter 1. Available from: https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK481862\/https:\/\/doi.org\/10.15586\/codon.cutaneousmelanoma.2017.ch1.","DOI":"10.15586\/codon.cutaneousmelanoma.2017.ch1"},{"key":"10.1038\/s41379-022-01138-z_bib2","unstructured":"U.S. Cancer Statistics Working Group. United States Cancer Statistics: 1999\u20132010 Incidence and Mortality Web-based report. Atlanta, GA: Centers for Disease Control and Prevention, U.S. Dept of Health and Human Services and National Cancer Institute, National Institutes of Health (2013)."},{"key":"10.1038\/s41379-022-01138-z_bib3","doi-asserted-by":"crossref","first-page":"2507","DOI":"10.1056\/NEJMoa1103782","article-title":"Improved survival with vemurafenib in melanoma with BRAF V600E mutation","volume":"364","author":"Chapman","year":"2011","journal-title":"N. Engl. J. Med"},{"key":"10.1038\/s41379-022-01138-z_bib4","doi-asserted-by":"crossref","unstructured":"Yang, K., Oak, A.S.W., Slominski, R.M., Bro\u017cyna, A.A., Slominski, A.T. Current molecular markers of melanoma and treatment targets. Int. J. Mol. Sci. 21, 3535 (2020). https:\/\/doi.org\/10.3390\/ijms21103535.","DOI":"10.3390\/ijms21103535"},{"key":"10.1038\/s41379-022-01138-z_bib5","doi-asserted-by":"crossref","first-page":"1681","DOI":"10.1016\/j.cell.2015.05.044","article-title":"Genomic Classification of Cutaneous Melanoma","volume":"161","author":"Cancer Genome Atlas Network","year":"2015","journal-title":"Cell"},{"key":"10.1038\/s41379-022-01138-z_bib6","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1126\/science.1229259","article-title":"Highly recurrent TERT promoter mutations in human melanoma","volume":"339","author":"Huang","year":"2013","journal-title":"Science"},{"key":"10.1038\/s41379-022-01138-z_bib7","doi-asserted-by":"crossref","first-page":"6172","DOI":"10.1038\/s41388-019-0872-9","article-title":"Mechanisms underlying the activation of TERT transcription and telomerase activity in human cancer: old actors and new players","volume":"38","author":"Yan","year":"2019","journal-title":"Oncogene"},{"key":"10.1038\/s41379-022-01138-z_bib8","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1002\/path.5039","article-title":"Ultraviolet light and melanoma","volume":"244","author":"Craig","year":"2018","journal-title":"J. Pathol"},{"key":"10.1038\/s41379-022-01138-z_bib9","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1111\/exd.14287","article-title":"Genetic drivers of non-cutaneous melanomas: challenges and opportunities in a heterogeneous landscape","volume":"31","author":"Vergara","year":"2021","journal-title":"Exp Dermatol"},{"key":"10.1038\/s41379-022-01138-z_bib10","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1038\/nrc3947","article-title":"The emerging complexity of gene fusions in cancer","volume":"15","author":"Mertens","year":"2015","journal-title":"Nat. Rev. Cancer"},{"key":"10.1038\/s41379-022-01138-z_bib11","doi-asserted-by":"crossref","first-page":"4845","DOI":"10.1038\/onc.2014.406","article-title":"The landscape and therapeutic relevance of cancer-associated transcript fusions","volume":"34","author":"Yoshihara","year":"2015","journal-title":"Oncogene"},{"key":"10.1038\/s41379-022-01138-z_bib12","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1038\/nm.2166","article-title":"Rearrangements of the RAF kinase pathway in prostate cancer, gastric cancer and melanoma","volume":"16","author":"Palanisamy","year":"2010","journal-title":"Nat Med"},{"key":"10.1038\/s41379-022-01138-z_bib13","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1111\/pcmr.12560","article-title":"Kinase gene fusions in defined subsets of melanoma","volume":"30","author":"Turner","year":"2017","journal-title":"Pigment. Cell. Melanoma. Res"},{"key":"10.1038\/s41379-022-01138-z_bib14","doi-asserted-by":"crossref","first-page":"1466","DOI":"10.1038\/s41379-020-0510-7","article-title":"Melanomas with activating RAF1 fusions: clinical, histopathologic, and molecular profiles","volume":"33","author":"Williams","year":"2020","journal-title":"Mod Pathol"},{"key":"10.1038\/s41379-022-01138-z_bib15","first-page":"1387","article-title":"NTRK gene fusions in melanoma: detection, prevalence and potential therapeutic implications","volume":"18","author":"Forschner","year":"2020","journal-title":"J. Dtsch. Dermatol. Ges"},{"key":"10.1038\/s41379-022-01138-z_bib16","doi-asserted-by":"crossref","first-page":"878","DOI":"10.1111\/cup.13521","article-title":"The role of gene fusions in melanocytic neoplasms","volume":"46","author":"Quan","year":"2019","journal-title":"J. Cutan. Pathol"},{"key":"10.1038\/s41379-022-01138-z_bib17","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1016\/S1470-2045(15)00488-X","article-title":"Alectinib in ALK-positive, crizotinib-resistant, non-small-cell lung cancer: a single-group, multicentre, phase 2 trial","volume":"17","author":"Shaw","year":"2016","journal-title":"Lancet Oncol"},{"key":"10.1038\/s41379-022-01138-z_bib18","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1111\/pcmr.12388","article-title":"Clinical activity of the MEK inhibitor trametinib in metastatic melanoma containing BRAF kinase fusion","volume":"28","author":"Menzies","year":"2015","journal-title":"Pigment. Cell. Melanoma. Res"},{"key":"10.1038\/s41379-022-01138-z_bib19","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1200\/PO.17.00138","article-title":"Significant clinical response to a MEK inhibitor therapy in a patient with metastatic melanoma harboring an RAF1 fusion","volume":"2","author":"Kim","year":"2018","journal-title":"JCO. Precis. Oncol"},{"key":"10.1038\/s41379-022-01138-z_bib20","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1158\/1535-7163.MCT-17-0472","article-title":"ALK inhibitor response in melanomas expression EML4-ALK fusions and alternate ALK isoforms","volume":"17","author":"Couts","year":"2018","journal-title":"Mol. Cancer. Ther"},{"key":"10.1038\/s41379-022-01138-z_bib21","doi-asserted-by":"crossref","first-page":"1940","DOI":"10.1172\/JCI123089","article-title":"Profound MEK inhibitor response in a cutaneous melanoma harboring a GOLGA4-RAF1 fusion","volume":"129","author":"McEvoy","year":"2019","journal-title":"J. Clin. Invest"},{"key":"10.1038\/s41379-022-01138-z_bib22","doi-asserted-by":"crossref","unstructured":"Chew, S.M., Lucas, M., Brady, M., Kelly, C.M. SKAP2-BRAF fusion and response to an MEK inhibitor in a patient with metastatic melanoma resistant to immunotherapy. BMJ. Case. Rep. 14, e238494 (2021). https:\/\/doi.org\/10.1136\/bcr-2020-238494.","DOI":"10.1136\/bcr-2020-238494"},{"key":"10.1038\/s41379-022-01138-z_bib23","doi-asserted-by":"crossref","unstructured":"Wiesner, T., He, J., Yelensky, R., Esteve-Puig, R., Botton, T., Yeh I. et al. Kinase fusions are frequent in Spitz tumours and spitzoid melanomas. Nat. Commun. 5, 3116 (2014). https:\/\/doi.org\/10.1038\/ncomms4116.","DOI":"10.1038\/ncomms4116"},{"key":"10.1038\/s41379-022-01138-z_bib24","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1016\/j.det.2013.06.012","article-title":"Spitz nevus, Spitz tumor, and Spitzoid melanoma: a comprehensive clinicopathologic overview","volume":"31","author":"Ferrara","year":"2013","journal-title":"Dermatol Clin"},{"key":"10.1038\/s41379-022-01138-z_bib25","doi-asserted-by":"crossref","first-page":"1132","DOI":"10.1111\/cup.13842","article-title":"BRAF fusion Spitz neoplasms; clinical morphological, and genomic findings in six cases","volume":"47","author":"Kim","year":"2020","journal-title":"J. Cutan. Pathol"},{"key":"10.1038\/s41379-022-01138-z_bib26","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1111\/pcmr.12129","article-title":"Identification of anaplastic lymphoma kinase break points and oncogenic mutation profiles in acral\/mucosal melanomas","volume":"26","author":"Niu","year":"2013","journal-title":"Pigment. Cell. Melanoma. Res"},{"key":"10.1038\/s41379-022-01138-z_bib27","doi-asserted-by":"crossref","first-page":"1479","DOI":"10.1038\/nm.3729","article-title":"Anchored multiplex PCR for targeted next-generation sequencing","volume":"20","author":"Zheng","year":"2014","journal-title":"Nat Med"},{"key":"10.1038\/s41379-022-01138-z_bib28","doi-asserted-by":"crossref","first-page":"1754","DOI":"10.1093\/bioinformatics\/btp324","article-title":"Fast and accurate short read alignment with Burrows-Wheeler transform","volume":"25","author":"Li","year":"2009","journal-title":"Bioinformatics"},{"key":"10.1038\/s41379-022-01138-z_bib29","first-page":"656","article-title":"BLAT \u2013 the BLAST-like alignment tool","volume":"12","author":"Kent","year":"2002","journal-title":"Genome Res"},{"key":"10.1038\/s41379-022-01138-z_bib30","doi-asserted-by":"crossref","first-page":"1356","DOI":"10.1634\/theoncologist.2018-0515","article-title":"Clinically integrated molecular diagnostics in adenoid cystic carcinoma","volume":"24","author":"Thierauf","year":"2019","journal-title":"Oncologist"},{"key":"10.1038\/s41379-022-01138-z_bib31","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1080\/14737140.2018.1489246","article-title":"The eighth edition American Joint Committee on Cancer (AJCC) melanoma staging system: implications for melanoma treatment and care","volume":"18","author":"Keung","year":"2018","journal-title":"Expert. Rev. Anticancer. Ther"},{"key":"10.1038\/s41379-022-01138-z_bib32","doi-asserted-by":"crossref","first-page":"3094","DOI":"10.1158\/0008-5472.CAN-08-0198","article-title":"Two unique novel prostate-specific and androgen-regulated fusion partners of ETV4 in prostate cancer","volume":"68","author":"Hermans","year":"2008","journal-title":"Cancer Res"},{"key":"10.1038\/s41379-022-01138-z_bib33","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1002\/(SICI)1098-2264(199602)15:2<115::AID-GCC6>3.0.CO;2-6","article-title":"Fusion of an ETS-family gene, EIAF, to EWS by t(17;22)(q12;q12) chromosome translocation in an undifferentiated sarcoma of infancy","volume":"15","author":"Kanedo","year":"1996","journal-title":"Genes. Chromosomes. Cancer"},{"key":"10.1038\/s41379-022-01138-z_bib34","doi-asserted-by":"crossref","first-page":"1154","DOI":"10.1002\/gcc.22003","article-title":"Survey of 548 oncogenic fusion transcripts in thyroid tumours supports the importance of the already established thyroid fusions genes","volume":"51","author":"Celestino","year":"2012","journal-title":"Genes. Chromosomes. Cancer"},{"key":"10.1038\/s41379-022-01138-z_bib35","doi-asserted-by":"crossref","first-page":"1646","DOI":"10.1038\/nm.2580","article-title":"Functionally recurrent rearrangements of the MAST kinase and Notch gene families in breast cancer","volume":"17","author":"Robinson","year":"2012","journal-title":"Nat Med"},{"key":"10.1038\/s41379-022-01138-z_bib36","first-page":"71","article-title":"Mutations in G protein beta subunits promote transformation and kinase inhibitor resistance","volume":"21","author":"Yoda","year":"2015","journal-title":"Nature"},{"key":"10.1038\/s41379-022-01138-z_bib37","doi-asserted-by":"crossref","unstructured":"Cao, Y., Li, J., Jia, Y., Zhang, R., Shi, H. Circ RNA circ_POLA2 promotes cervical squamous cell carcinoma progression via regulating miR-326\/GNB1. Front. Oncol. 10, 959 (2020) https:\/\/doi.org\/10.3389\/fonc.2020.00959.","DOI":"10.3389\/fonc.2020.00959"},{"key":"10.1038\/s41379-022-01138-z_bib38","doi-asserted-by":"crossref","unstructured":"Ei\u00dfmann, M., Schwamb, B., Melzer, I.M., Moser, J., Siele, D., Kohl, U. et al. A functional yeast survival screen of tumor-derived cDNA libraries designed to identify anti-apoptotic mammalian oncogenes. PLoS. One. 8, e64873 (2013) https:\/\/doi.org\/10.1371\/journal.pone.0064873.","DOI":"10.1371\/journal.pone.0064873"},{"key":"10.1038\/s41379-022-01138-z_bib39","doi-asserted-by":"crossref","unstructured":"Jiao, Y., Li, Y., Jiang, P., Fu, Z., Liu, Y. High MAST2 mRNA expression and its role in diagnosis and prognosis of liver cancer. Sci. Rep. 9, 19865 (2019) https:\/\/doi.org\/10.1038\/s41598-019-56476-x.","DOI":"10.1038\/s41598-019-56476-x"},{"key":"10.1038\/s41379-022-01138-z_bib40","doi-asserted-by":"crossref","unstructured":"Stransky, N., Cerami, E., Schalm, S., Kim, J.L., Lengauer, C. The landscape of kinase fusions in cancer. Nat. Commun. 5, 4846 (2014). https:\/\/doi.org\/10.1038\/ncomms5846.","DOI":"10.1038\/ncomms5846"},{"key":"10.1038\/s41379-022-01138-z_bib41","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1016\/j.celrep.2019.09.009","article-title":"Genetic heterogeneity of BRAF fusion kinases in melanoma affects drug responses","volume":"29","author":"Botton","year":"2019","journal-title":"Cell Rep"},{"key":"10.1038\/s41379-022-01138-z_bib42","doi-asserted-by":"crossref","first-page":"5631","DOI":"10.1158\/1078-0432.CCR-16-0758","article-title":"BRAF fusion as a novel mechanism of acquired resistance to Vemurafenib in BRAFV600E mutation melanoma","volume":"23","author":"Kulkarni","year":"2017","journal-title":"Clin. Cancer. Res"},{"key":"10.1038\/s41379-022-01138-z_bib43","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1038\/nrm3979","article-title":"Regulation of RAF protein kinases in ERK signaling","volume":"16","author":"Lavole","year":"2015","journal-title":"Nat. Rev. Mol. Cell. Biol"},{"key":"10.1038\/s41379-022-01138-z_bib44","doi-asserted-by":"crossref","first-page":"2119","DOI":"10.1038\/onc.2009.73","article-title":"Oncogenic RAF1 rearrangement and a novel BRAF mutation as alternatives to KIAA1549:BRAF fusion in activating the MAPK pathway in pilocytic astrocytoma","volume":"28","author":"Jones","year":"2009","journal-title":"Oncogene"},{"key":"10.1038\/s41379-022-01138-z_bib45","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1038\/nature22071","article-title":"Whole-genome landscapes of major melanoma subtypes","volume":"545","author":"Hayward","year":"2017","journal-title":"Nature"},{"key":"10.1038\/s41379-022-01138-z_bib46","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1111\/pcmr.12785","article-title":"Malignant melanoma with areas of rhabdomyosarcomatous differentiation arising in a giant congenital nevus with RAF1 gene fusion","volume":"32","author":"Baltres","year":"2019","journal-title":"Pigment. Cell. Melanoma. Res"},{"key":"10.1038\/s41379-022-01138-z_bib47","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.1111\/cup.13817","article-title":"Novel LRRFIP2-RAF1 fusion identified in an acral melanoma: a review of the literature on melanocytic proliferations with RAF1 fusions and the potential therapeutic implications","volume":"47","author":"LeBlanc","year":"2020","journal-title":"J. Cutan. Pathol"},{"key":"10.1038\/s41379-022-01138-z_bib48","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/j.pathol.2015.12.007","article-title":"Genomic aberrations in Spitzoid melanocytic tumors and their implications for diagnosis, prognosis and therapy","volume":"48","author":"Wiesner","year":"2016","journal-title":"Pathology"},{"key":"10.1038\/s41379-022-01138-z_bib49","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.humpath.2019.03.002","article-title":"Fusion of ALK to the melanophilin gene MLPH in pediatric Spitz nevi","volume":"87","author":"Chung","year":"2019","journal-title":"Hum Pathol"},{"key":"10.1038\/s41379-022-01138-z_bib50","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.humpath.2018.02.021","article-title":"A case report of atypical Spitz tumor harboring a novel MLPH-ALK gene fusion with discordant ALK immunohistochemistry results","volume":"80","author":"Fujimoto","year":"2018","journal-title":"Hum Pathol"},{"key":"10.1038\/s41379-022-01138-z_bib51","doi-asserted-by":"crossref","first-page":"948","DOI":"10.1111\/cup.14005","article-title":"Observed progression from melanosis with melanocyte hyperplasia to sinonasal melanoma with distant metastasis and a unique genetic rearrangement","volume":"48","author":"Salari","year":"2021","journal-title":"J. Cutan. Pathol"},{"key":"10.1038\/s41379-022-01138-z_bib52","doi-asserted-by":"crossref","first-page":"1938","DOI":"10.3390\/curroncol28030180","article-title":"Successful Alectinib treatment for carcinoma of unknown primary with EML4-ALK fusion gene: a case report","volume":"28","author":"Sugiyama","year":"2021","journal-title":"Curr Oncol"},{"key":"10.1038\/s41379-022-01138-z_bib53","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1101\/gr.213348.116","article-title":"Integrated genomic analyses reveal frequent TERT aberrations in acral melanoma","volume":"27","author":"Liang","year":"2017","journal-title":"Genome Res"},{"key":"10.1038\/s41379-022-01138-z_bib54","doi-asserted-by":"crossref","unstructured":"Zhang, R., Dong, L., Yu, J. Concomitant pathogenic mutations and fusions of driver oncogenes in tumors. Front. Oncol. 10, 544579 (2021). https:\/\/doi.org\/10.3389\/fonc.2020.544579.","DOI":"10.3389\/fonc.2020.544579"},{"key":"10.1038\/s41379-022-01138-z_bib55","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/j.celrep.2018.03.050","article-title":"Driver fusions and their implications in the development and treatment of human cancers","volume":"23","author":"Gao","year":"2018","journal-title":"Cell Rep"}],"container-title":["Modern Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41379-022-01138-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41379-022-01138-z","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0893395222054965?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0893395222054965?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41379-022-01138-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,12]],"date-time":"2025-10-12T01:24:59Z","timestamp":1760232299000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0893395222054965"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,12]]},"references-count":55,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2022,12]]}},"alternative-id":["S0893395222054965"],"URL":"https:\/\/doi.org\/10.1038\/s41379-022-01138-z","relation":{},"ISSN":["0893-3952"],"issn-type":[{"value":"0893-3952","type":"print"}],"subject":[],"published":{"date-parts":[[2022,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Identification of fusions with potential clinical significance in melanoma","name":"articletitle","label":"Article Title"},{"value":"Modern Pathology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1038\/s41379-022-01138-z","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 United States & Canadian Academy of Pathology.","name":"copyright","label":"Copyright"}]}}